Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ADMS - Adamas: How We Got Here And What The Future Brings

ADMS - Adamas: How We Got Here And What The Future Brings

Adamas Pharmaceuticals Inc.
  • Adamas has become much less exciting the last few years with sales of GOCOVRI slowing in its second year.
  • They decided to give up on attempting to treat the walking speed in those with Multiple Sclerosis with GOCOVRI after lackluster results.
  • Hope remains with a new CEO, Neil McFarlane, in 2019 who has done very well cutting costs while accelerating growth of revenues.
  • I predict they will make it to cash flow positive in 2022, so their value will be determined by what peak sales are looking like.

For further details see:

Adamas: How We Got Here And What The Future Brings
Stock Information
Company Name: Adamas Pharmaceuticals Inc.
Stock Symbol: ADMS
Market: NASDAQ
Website: adamaspharma.com
Menu
ADMS ADMS Quote ADMS Short ADMS News ADMS Articles ADMS Message Board
Get ADMS Alerts

News, Short Squeeze, Breakout and More Instantly...